Table 2.
Oncogene Induced Senescence HYPs | Expected Direction | Test Data set |
---|---|---|
GSE28464 | ||
Predicted in consistent directions | ||
BNIP3L | ||
cell aging | ||
ETS2 | ||
FOXO1 | ||
gtpof(Ras family Hs) | ||
HBP1 | ||
HRAS | ||
HRAS mutated at G12V | ||
IFNG | ||
IL1A | ||
kaof(MAP2K1) | ||
kaof(MAP2K6) | ||
kaof(MEK Family Hs) | ||
kaof(p38 MAPK family Hs) | ||
kaof(RAF1) | ||
LIF | ||
MAP2K1 | ||
MAP2K6 | ||
MIF | ||
Oncogene induced senescence | ||
OSM | ||
PPBP | ||
RAF1 | ||
RAS Family Hs | ||
SMARCB1 | ||
taof(ETS2) | ||
taof(FOXO1) | ||
VEGFA | ||
Predicted in inconsistent directions | ||
KRAS | ||
KRAS mutated at G12V |
Notes: Expected direction is based on internal causality of the oncogene-induced senescence submodel. Yellow = predicted increase in abundance or activity; blue = predicted decrease in abundance or activity. Submodel nodes that are shared with other senescence models are bolded.
Abbreviations: gtpof(X), GTP-bound activity of X; kaof(X), kinase activity of X; taof(X), transcriptional activity of X.